AUTL
Autolus Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
AUTL fundamentals
Autolus Therapeutics (AUTL) released its earnings on Nov 12, 2025: revenue was 21.19M (YoY +11201.33%), missed estimates; EPS was -0.3 (YoY +3.23%), missed estimates.
Revenue / YoY
21.19M
+11201.33%
EPS / YoY
-0.3
+3.23%
Report date
Nov 12, 2025
AUTL Earnings Call Summary for Q3,2025
- Q3 Sales Beat Expectations: $21.1M in AUCATZYL revenue with $7.6M deferred revenue, signaling strong Q4 demand.
- Market Leadership Solidified: 20% CAR-T share in active centers, expanding to 60+ treatment centers.
- Operational Efficiency Push: New leadership team driving $367M cash runway for 2026 expansion.
- Autoimmune Pipeline Momentum: LUMINA (lupus nephritis) and BOBCAT (MS) trials initiated, with CARLYSLE showing 5/6 remissions.
- Gross Margin Outlook: Improvements expected through 2026 as manufacturing scales and automation implemented.
EPS
Revenue
Revenue & Expenses
AUTL has released its 2025 Q3 earnings report, with revenue of 21.19M, reflecting a YoY change of NaN%, and net profit of -79.12M, showing a YoY change of 3.63%. The Sankey diagram below clearly presents AUTL's revenue sources and cost distribution.
Key Indicators
Autolus Therapeutics (AUTL) key financial stats and ratios, covering profitability, financial health, and leverage.
Autolus Therapeutics (AUTL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Autolus Therapeutics (AUTL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Autolus Therapeutics (AUTL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Autolus Therapeutics (AUTL) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Autolus Therapeutics (AUTL) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Autolus Therapeutics's revenue and profit?Did Autolus Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Autolus Therapeutics's earnings call?What is Autolus Therapeutics's latest dividend and current dividend yield?What does Autolus Therapeutics do and what are its main business segments?What is Autolus Therapeutics's gross profit margin?What were the key takeaways from Autolus Therapeutics’s earnings call?What guidance did Autolus Therapeutics's management provide for the next earnings period?
